Literature DB >> 19474567

The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.

Sandra Weintraub1, David Salmon, Nathaniel Mercaldo, Steven Ferris, Neill R Graff-Radford, Helena Chui, Jeffrey Cummings, Charles DeCarli, Norman L Foster, Douglas Galasko, Elaine Peskind, Woodrow Dietrich, Duane L Beekly, Walter A Kukull, John C Morris.   

Abstract

The neuropsychologic test battery from the Uniform Data Set (UDS) of the Alzheimer's Disease Centers (ADC) program of the National Institute on Aging consists of brief measures of attention, processing speed, executive function, episodic memory, and language. This paper describes development of the battery and preliminary data from the initial UDS evaluation of 3268 clinically cognitively normal men and women collected over the first 24 months of utilization. The subjects represent a sample of community-dwelling, individuals who volunteer for studies of cognitive aging. Subjects were considered "clinically cognitively normal" based on clinical assessment, including the Clinical Dementia Rating scale and the Functional Assessment Questionnaire. The results demonstrate performance on tests sensitive to cognitive aging and to the early stages of Alzheimer disease in a relatively well-educated sample. Regression models investigating the impact of age, education, and sex on test scores indicate that these variables will need to be incorporated in subsequent normative studies. Future plans include: (1) determining the psychometric properties of the battery; (2) establishing normative data, including norms for different ethnic minority groups; and (3) conducting longitudinal studies on cognitively normal subjects, individuals with mild cognitive impairment, and individuals with Alzheimer disease and other forms of dementia.

Entities:  

Mesh:

Year:  2009        PMID: 19474567      PMCID: PMC2743984          DOI: 10.1097/WAD.0b013e318191c7dd

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  75 in total

Review 1.  Memory decline: the boundary between aging and age-related disease.

Authors:  Marilyn S Albert
Journal:  Ann Neurol       Date:  2002-03       Impact factor: 10.422

Review 2.  Memory aging from 18 to 80.

Authors:  Timothy A Salthouse
Journal:  Alzheimer Dis Assoc Disord       Date:  2003 Jul-Sep       Impact factor: 2.703

3.  Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum.

Authors:  Marsel Mesulam; Pamela Shaw; Deborah Mash; Sandra Weintraub
Journal:  Ann Neurol       Date:  2004-06       Impact factor: 10.422

Review 4.  Current concepts in mild cognitive impairment.

Authors:  R C Petersen; R Doody; A Kurz; R C Mohs; J C Morris; P V Rabins; K Ritchie; M Rossor; L Thal; B Winblad
Journal:  Arch Neurol       Date:  2001-12

5.  Preclinical prediction of AD using neuropsychological tests.

Authors:  M S Albert; M B Moss; R Tanzi; K Jones
Journal:  J Int Neuropsychol Soc       Date:  2001-07       Impact factor: 2.892

6.  Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals.

Authors:  D P Salmon; R G Thomas; M M Pay; A Booth; C R Hofstetter; L J Thal; R Katzman
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

Review 7.  Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease.

Authors:  Eva Arnáiz; Ove Almkvist
Journal:  Acta Neurol Scand Suppl       Date:  2003

8.  Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.

Authors:  Angela L Guillozet; Sandra Weintraub; Deborah C Mash; M Marsel Mesulam
Journal:  Arch Neurol       Date:  2003-05

9.  Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals.

Authors:  Dorene M Rentz; Terri J Huh; Robert R Faust; Andrew E Budson; Leonard F M Scinto; Reisa A Sperling; Kirk R Daffner
Journal:  Neuropsychology       Date:  2004-01       Impact factor: 3.295

10.  Amnestic MCI or prodromal Alzheimer's disease?

Authors:  Bruno Dubois; Martin L Albert
Journal:  Lancet Neurol       Date:  2004-04       Impact factor: 44.182

View more
  431 in total

1.  Detection of Mild Cognitive Impairment Among Community-Dwelling African Americans Using the Montreal Cognitive Assessment.

Authors:  Heidi C Rossetti; Emily E Smith; Linda S Hynan; Laura H Lacritz; C Munro Cullum; Aaron Van Wright; Myron F Weiner
Journal:  Arch Clin Neuropsychol       Date:  2019-08-28       Impact factor: 2.813

2.  Self-ratings of Spoken Language Dominance: A Multi-Lingual Naming Test (MINT) and Preliminary Norms for Young and Aging Spanish-English Bilinguals.

Authors:  Tamar H Gollan; Gali H Weissberger; Elin Runnqvist; Rosa I Montoya; Cynthia M Cera
Journal:  Biling (Camb Engl)       Date:  2012-07

3.  Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.

Authors:  Sylvia E Perez; Damianka P Getova; Bin He; Scott E Counts; Changiz Geula; Laurent Desire; Severine Coutadeur; Helene Peillon; Stephen D Ginsberg; Elliott J Mufson
Journal:  Am J Pathol       Date:  2011-12-03       Impact factor: 4.307

Review 4.  Noninvasive brain stimulation in Alzheimer's disease: systematic review and perspectives for the future.

Authors:  Catarina Freitas; Helena Mondragón-Llorca; Alvaro Pascual-Leone
Journal:  Exp Gerontol       Date:  2011-04-14       Impact factor: 4.032

5.  An exploration of subgroups of mild cognitive impairment based on cognitive, neuropsychiatric and functional features: analysis of data from the National Alzheimer's Coordinating Center.

Authors:  John J Hanfelt; Joanne Wuu; Ann B Sollinger; Melanie C Greenaway; James J Lah; Allan I Levey; Felicia C Goldstein
Journal:  Am J Geriatr Psychiatry       Date:  2011-11       Impact factor: 4.105

6.  Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.

Authors:  John C Morris
Journal:  Arch Neurol       Date:  2012-06

7.  Quantitative classification of primary progressive aphasia at early and mild impairment stages.

Authors:  M-Marsel Mesulam; Christina Wieneke; Cynthia Thompson; Emily Rogalski; Sandra Weintraub
Journal:  Brain       Date:  2012-04-23       Impact factor: 13.501

8.  Predicting cognitive decline and conversion to Alzheimer's disease in older adults using the NAB List Learning test.

Authors:  Brandon E Gavett; Al Ozonoff; Vlada Doktor; Joseph Palmisano; Anil K Nair; Robert C Green; Angela L Jefferson; Robert A Stern
Journal:  J Int Neuropsychol Soc       Date:  2010-04-07       Impact factor: 2.892

9.  Neuropsychological test performance and cognitive reserve in healthy aging and the Alzheimer's disease spectrum: a theoretically driven factor analysis.

Authors:  Meghan B Mitchell; Lynn W Shaughnessy; Steven D Shirk; Frances M Yang; Alireza Atri
Journal:  J Int Neuropsychol Soc       Date:  2012-10-08       Impact factor: 2.892

10.  Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.

Authors:  Whitney Wharton; Felicia C Goldstein; Liping Zhao; Kyle Steenland; Allan I Levey; Ihab Hajjar
Journal:  J Am Geriatr Soc       Date:  2015-09       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.